Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04084990 · ClinicalTrials.gov registry record · Phase 3
Sleep Apnea and Fetal Growth Restriction
A Phase 3 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT04084990 is a Phase 3 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT04084990, a Phase 3 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study aims to evaluate the association between obstructive sleep apnea (OSA) and fetal growth restriction (FGR) and to assess the role of auto-titrated positive airway pressure (aPAP) as antenatal therapy in these patients. Pregnant patients with diagnosed FGR will be screened for OSA first by screening questionnaire and then by home sleep monitor. Of those patients diagnosed with OSA, half will be assigned to use aPAP each night when sleeping and half will not (standard care).
Interventions
- DEVICE S9 VPAP Adapt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-11-18 |
| Est. Completion | 2021-07-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04084990
The ClinicalTrials.gov registry entry for NCT04084990 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S9 VPAP Adapt is the first listed.
NCT04084990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04084990 about?
NCT04084990 is a clinical study titled "Sleep Apnea and Fetal Growth Restriction". This study aims to evaluate the association between obstructive sleep apnea (OSA) and fetal growth restriction (FGR) and to assess the role of auto-titrated positive airway pressure (aPAP) as antenatal therapy in these patients. Pregnant patients with diagnosed FGR will be screened for OSA first by ...
What is the current status of trial NCT04084990?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2019-11-18. Estimated completion is 2021-07-27.
What interventions are being tested in trial NCT04084990?
The interventions under investigation include: S9 VPAP Adapt (DEVICE).
Who is sponsoring clinical trial NCT04084990?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.